Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

Saved in:
Bibliographic Details
Title: Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.
Authors: Kostopoulos IV; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Rousakis P; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Malandrakis P; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Panteli C; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Eleutherakis-Papaiakovou E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Angelis N; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Spiliopoulou V; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Syrigou RE; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Bakouros P; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Dimitrakopoulou G; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Fotiou D; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Migkou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Kanellias N; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Paschalidis N; Mass Cytometry-CyTOF Laboratory, Center for Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Tsitsilonis OE; Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Source: American journal of hematology [Am J Hematol] 2024 Oct; Vol. 99 (10), pp. 1887-1896. Date of Electronic Publication: 2024 Jun 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first